[TamDenholm]

In the world of business acquisitions, to which I’m no expert but know a little, it’s not worth it for private equity firms to even look at businesses operating in less than probably 25 million in revenue, because it takes (near enough) the same amount of effort to acquire a business doing 25 million as a business doing 500k revenue.

However, for a player like me, it’s worth me operating in the 500k to 25mil range and buying businesses there because, first off I’m not a millionaire, and second, I can assemble a group of related small businesses which collectively would make 25 million which I can then sell to private equity for a larger multiple than I bought them for.

My point being, is there a way to create some kind of collective of rare disease causes and raise money as a group, collectively funding the labs and salaries of scientists to work on these diseases, ideally in an efficient way so that the work done on one disease can, at least partially, be effective for a number of the diseases in the group.

I don’t know the answer, I just wanted to offer an idea from my perspective.